@fd
Agreed. This feels like a last-ditch effort to breathe new life into Albany’s floundering nanosheet work that Huiming has championed for years. It is his passion project.
The problem is that the industry either wasn’t interested in IBM’s implementation or developed its own versions. As a result, IBM generated essentially no meaningful licensing revenue from the technology. While IBM made genuine scientific contributions, the basic nanosheet concept wasn’t created or invented there. It was already being explored and advanced by multiple companies and research groups. IBM largely built upon an existing industry direction rather than creating it. They copied it.
From a research perspective, it’s an impressive accomplishment. From a business perspective, it’s hard to argue it was a success. After years of investment in time, resources, and manpower, where is the return on investment?
Even Huiming has acknowledged in his posts for years now has mentioned one of the most common questions he receives is when the industry will adopt IBM’s technology. The reality is that no one appears poised to adopt IBM’s specific implementation. Or ever will even entertain it.
This latest announcement feels like doubling down on the same strategy. IBM itself is saying commercial high-volume manufacturing could be five years away. In the semiconductor industry, five years is an eternity. By then, newer, better, and—most importantly—more cost-effective solutions will likely exist.
Nanosheet and stacked nanosheet technologies absolutely have a future. But if they become commercially successful, the revenue is far more likely to come from companies like Intel, Samsung, or TSMC with their own manufacturing-ready implementations just not IBM’s. So it’s almost a waste of time and money.
That’s what makes IBM’s strategy so puzzling. The company continues to invest heavily in technologies that generate impressive headlines and publications but have struggled to translate into meaningful licensing revenue or commercial return.